{"nctId":"NCT00432835","briefTitle":"Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis","startDateStruct":{"date":"2005-08"},"conditions":["Gastroparesis"],"count":58,"armGroups":[{"label":"Gastric Stimulation Days1-4/Sham5-8","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Gastric Electrical Stimulator, Enterra, Medtronics, Inc."]},{"label":"Sham1-4/Gastric Stimulation Days5-8","type":"ACTIVE_COMPARATOR","interventionNames":["Device: Gastric Electrical Stimulator, Enterra, Medtronics, Inc."]}],"interventions":[{"name":"Gastric Electrical Stimulator, Enterra, Medtronics, Inc.","otherNames":["No other name currently exists."]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Sex: Male of Female\n* Age Range: 18 to 70 inclusive\n* Patients with GP of diabetic, surgically related or idiopathic etiology.\n* Symptoms of GP for \\>/= 1 year.\n* Refractory or intolerant to antiemetic drug classes (antihistamines and phenothiazines, serotonin receptor antagonists, dopamine receptor antagonists)\n* Chronic vomiting and/or nausea with 7 or more episodes per week for either symptom irrespective of GET values.\n* The patient is willing and able to provide informed consent.\n* The patient is willing and able to return for required follow-up visits.\n\nExclusion Criteria:\n\n* Patients \\< 18 or \\>70 years in age.\n* Patients with an active infection of any kind.\n* Patients who the investigator determines are not candidates for endoscopic procedures.\n* Women who are pregnant\n* Inability or unwillingness to provide informed consent\n* Unwilling or unable to return for required follow-up visits and examinations.\n* Patients who are currently enrolled in another investigation of a medical device or drug.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Symptom of Vomiting Associated With Gastroparesis","description":"Likert Scale 0-4 (low-high) using a patient reported outcomes tool","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.82","spread":"1.55"},{"groupId":"OG001","value":"2.68","spread":"1.61"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.17","spread":"0.67"},{"groupId":"OG001","value":"1.20","spread":"1.47"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.91","spread":"1.44"},{"groupId":"OG001","value":"0.72","spread":"1.17"}]}]}]},{"type":"PRIMARY","title":"Symptom of Nausea Associated With Gastroparesis","description":"Likert Scale 0-4 (low-high) using a patient reported outcomes tool","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.27","spread":"0.92"},{"groupId":"OG001","value":"3.33","spread":"1.03"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.46","spread":"1.29"},{"groupId":"OG001","value":"1.67","spread":"1.49"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.26","spread":"1.18"},{"groupId":"OG001","value":"1.4","spread":"1.38"}]}]}]},{"type":"PRIMARY","title":"Symptom of Gastric Emptying Time (GET) Associated With Gastroparesis","description":"Transit time of a radio-labeled meal through the stomach, measured by scintigraphy for %contents remaining in the stomach at 1 hour, 2 hours, and 4 hours. GET measures were obtained at baseline, during the period allowed for 'washout', and on the final study day.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67.07","spread":"20.23"},{"groupId":"OG001","value":"66.13","spread":"25.37"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.96","spread":"23.79"},{"groupId":"OG001","value":"37.41","spread":"28.06"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64.71","spread":"21.10"},{"groupId":"OG001","value":"16.43","spread":"23.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"69.96","spread":"23.79"},{"groupId":"OG001","value":"62.35","spread":"24.75"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"46.85","spread":"25.30"},{"groupId":"OG001","value":"38.00","spread":"24.64"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.11","spread":"23.76"},{"groupId":"OG001","value":"21.85","spread":"28.51"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64.71","spread":"21.10"},{"groupId":"OG001","value":"68.67","spread":"19.92"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.19","spread":"24.37"},{"groupId":"OG001","value":"40.92","spread":"26.50"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"24.71","spread":"27.94"},{"groupId":"OG001","value":"20.25","spread":"25.26"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":51},"commonTop":["Lead Dislodgment"]}}}